Related references
Note: Only part of the references are listed.Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
Fasiha Kanwal et al.
HEPATOLOGY (2020)
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease: Expert Review
Rohit Loomba et al.
GASTROENTEROLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016
M. H. Le et al.
JOURNAL OF INTERNAL MEDICINE (2020)
Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort
Vincent L. Chen et al.
LIVER INTERNATIONAL (2020)
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data
Rohit Loomba et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis
Kazuhisa Kodama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
Bonnie Bengtsson et al.
LIVER INTERNATIONAL (2019)
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
Fasiha Kanwal et al.
GASTROENTEROLOGY (2019)
Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study
Haesuk Park et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
Tracey G. Simon et al.
ANNALS OF INTERNAL MEDICINE (2019)
Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis
Debra T. Choi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality
Aaron P. Thrift et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases
Jie Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross-Sectional Population-Based Study on Its Relationship From 1999 to 2016
Michael H. Le et al.
HEPATOLOGY COMMUNICATIONS (2019)
Projections of primary liver cancer to 2030 in 30 countries worldwide
Patricia C. Valery et al.
HEPATOLOGY (2018)
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue
Changqing Zhao et al.
LIVER INTERNATIONAL (2018)
Anti-viral therapy is associated with improved survival but is underutilised in patients with hepatitis B virus-related hepatocellular carcinoma: real-world east and west experience
V. L. Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Should we undertake surveillance for HCC in patients with NAFLD?
Ramy Younes et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases
Jonathan G. Stine et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
Omair Atiq et al.
HEPATOLOGY (2017)
Comparison of Laboratory Tests, Ultrasound, or Magnetic Resonance Elastography to Detect Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Guangqin Xiao et al.
HEPATOLOGY (2017)
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
Maneerat Chayanupatkul et al.
JOURNAL OF HEPATOLOGY (2017)
Nonalcoholic Fatty Liver Disease-Related Cirrhosis Is Commonly Unrecognized and Associated With Hepatocellular Carcinoma
Luis C. Bertot et al.
HEPATOLOGY COMMUNICATIONS (2017)
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis
Bashar Mohamad et al.
HEPATOLOGY INTERNATIONAL (2016)
Effects of Cirrhosis on Short-term and Long-term Survival of Patients With Hepatitis B-related Hepatocellular Carcinoma
Vincent L. Chen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
PNPLA3 gene in liver diseases
Eric Trépo et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009
Zobair M. Younossi et al.
HEPATOLOGY (2015)
Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease
Christopher Leung et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Nonalcoholic Steatohepatitis Is the Most Rapidly Growing Indication for Liver Transplantation in Patients With Hepatocellular Carcinoma in the U. S.
Robert J. Wong et al.
HEPATOLOGY (2014)
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals
Maria Antonella Burza et al.
DIGESTIVE AND LIVER DISEASE (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
Judith Ertle et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Share Paper
